India’s Pharma and Healthcare Deals Hold Strong at Dollar 13.9 Billion in Q2 2026
July 23: India’s pharmaceutical and healthcare sectors continued to attract strong investor interest, with deal activity remaining resilient at $13.9 billion in the second quarter of 2026, reflecting confidence in the long-term growth potential of the industry. The sector maintained momentum amid evolving global market conditions, supported by rising healthcare demand, innovation-driven growth, and increasing […]
India’s Pharma and Healthcare Deals Hold Strong at Dollar 13.9 Billion in Q2 2026 Read More »